Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoyuki Sugimoto

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Pharmaceutical Statistics|March 15, 2012
A convenient formula for sample size calculations in clinical trials with multiple co-primary continuous endpointsTomoyuki Sugimoto, Takashi Sozu, Toshimitsu Hamasaki
Biometrical Journal. Biometrische Zeitschrift|July 26, 2012
Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variablesTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Journal of Biopharmaceutical Statistics|April 26, 2011
Sample size determination in superiority clinical trials with multiple co-primary correlated endpointsTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Statistics in Medicine|August 6, 2010
Sample size determination in clinical trials with multiple co-primary binary endpointsTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Biometrical Journal. Biometrische Zeitschrift|July 10, 2013
Authors' replyTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Pharmaceutical Statistics|October 20, 2012
Sample size determination for clinical trials with co-primary outcomes: exponential event timesToshimitsu Hamasaki, Tomoyuki Sugimoto, Scott Evans, et al.
BMC Medical Research Methodology|April 24, 2010
Practical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorderIchiro Arano, Tomoyuki Sugimoto, Toshimitsu Hamasaki, et al.
Biostatistics (Oxford, England)|January 12, 2013
A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpointsTomoyuki Sugimoto, Takashi Sozu, Toshimitsu Hamasaki, et al.
Lifetime Data Analysis|April 14, 2019
Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomesTomoyuki Sugimoto, Toshimitsu Hamasaki, Scott R Evans, et al.
Biostatistics (Oxford, England)|June 18, 2016
Corrigendum: A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints (10.1093/biostatistics/kxs057)Tomoyuki Sugimoto, Takashi Sozu, Toshimitsu Hamasaki, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Pharmaceutical Statistics|March 15, 2012
A convenient formula for sample size calculations in clinical trials with multiple co-primary continuous endpointsTomoyuki Sugimoto, Takashi Sozu, Toshimitsu Hamasaki
Biometrical Journal. Biometrische Zeitschrift|July 26, 2012
Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variablesTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Journal of Biopharmaceutical Statistics|April 26, 2011
Sample size determination in superiority clinical trials with multiple co-primary correlated endpointsTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Statistics in Medicine|August 6, 2010
Sample size determination in clinical trials with multiple co-primary binary endpointsTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Biometrical Journal. Biometrische Zeitschrift|July 10, 2013
Authors' replyTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Pharmaceutical Statistics|October 20, 2012
Sample size determination for clinical trials with co-primary outcomes: exponential event timesToshimitsu Hamasaki, Tomoyuki Sugimoto, Scott Evans, et al.
BMC Medical Research Methodology|April 24, 2010
Practical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorderIchiro Arano, Tomoyuki Sugimoto, Toshimitsu Hamasaki, et al.
Biostatistics (Oxford, England)|January 12, 2013
A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpointsTomoyuki Sugimoto, Takashi Sozu, Toshimitsu Hamasaki, et al.
Lifetime Data Analysis|April 14, 2019
Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomesTomoyuki Sugimoto, Toshimitsu Hamasaki, Scott R Evans, et al.
Biostatistics (Oxford, England)|June 18, 2016
Corrigendum: A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints (10.1093/biostatistics/kxs057)Tomoyuki Sugimoto, Takashi Sozu, Toshimitsu Hamasaki, et al.
Pageof 5